New nanoparticle technology offers hope for hard-to-treat diseases GlobeNewswire January 22, 2026 Sydney, Australia, Jan. 21, 2026 (GLOBE NEWSWIRE) — A newly published paper in Nature Nanotechnology details groundbreaking nanoparticle technology, with research led by University of Technology Chair Professor in Nanomedicine Bingyang Shi. A newly published perspective article in Nature Nanotechnology details groundbreaking nanoparticle […]

Sydney, Australia, Jan. 21, 2026 (GLOBE NEWSWIRE) — A newly published paper in Nature Nanotechnology details groundbreaking nanoparticle technology, with research led by University of Technology Chair Professor in Nanomedicine Bingyang Shi. A newly published perspective article in Nature Nanotechnology details groundbreaking nanoparticle technology to eliminate harmful, disease-causing proteins in the body. The technology marks

Ulaanbaatar, Mongolia–(Newsfile Corp. – January 21, 2026) – Steppe Gold Ltd. (TSX: STGO) (OTCQX: STPGF) (FSE: 2J9) (“Steppe Gold” or the “Company“) is pleased to provide a corporate update. Fourth Quarter Production Company 2025 fourth quarter gold production was 29,280 oz, higher than updated guidance of 23,000 oz. Unaudited gold sales for the quarter was

NEWTOWN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at MemberClose LLC (“MemberClose”). MemberClose learned of a data breach on or about October 30, 2025. If you would like to discuss this case with a lawyer, please click HERE. About MemberClose

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of MemberClose LLC Customers Whose Data May Have Been Compromised GlobeNewswire January 22, 2026 NEWTOWN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at MemberClose LLC (“MemberClose”). MemberClose learned of

(NasdaqGM:CRVS), SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 7,900,677 shares of its common stock at a price to the public of $22.15 per share. Gross proceeds from the underwritten public offering before

Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock GlobeNewswire January 22, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 7,900,677 shares of its common stock at a price to

NEWTOWN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Insurance Office of America (“IOA”). IOA learned of a data breach on or about June 30, 2025. If you would like to discuss this case with a lawyer, please click HERE.

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Insurance Office of America Customers Whose Data May Have Been Compromised GlobeNewswire January 22, 2026 NEWTOWN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Insurance Office of America

NEWTOWN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Civil Service Employees Association Inc. (“CSEA”). CSEA learned of a data breach on or about May 30, 2025. If you would like to discuss this case with a lawyer, please click